Como se describi anteriormente en efectos sobre MACE, AR GLP-1 RA reduce principalmente los resultados asociados con ECV, como infarto de miocardio, accidente cerebrovascular y muerte cardiovascular, mientras que SGLT2i conduce a una reduccin pronunciada en el riesgo de muerte cardiovascular y IC, pero tambin reduce el infarto de miocardio
References & Further Reading Full prescribing info for Mounjaro on Medicines.org.uk NHS guidance on weight management injections Weight Loss Consultation 50 FREE One hour consultation with our professional and highly trained weight loss inj experts Initial Weight Loss Treatment 225 137 Weight Loss Inj Treatment Weight Loss Aftercare & Support 50 FREE Dedicated follow-up support with the highest expertise of weight loss inj Total 325 137
22 More recent research indicates that tirzepatide induces greater reductions in total and visceral fat mass compared with other GLP-1 RAs
June 06, 2023 Does supplementing with a probiotic help lower cholesterol or triglycerides in people with high cholesterol
Recent approvals have expanded its use for patients with chronic kidney disease, helping to slow kidney function decline and reduce the risk of kidney failure
The practical reality: neither medication is clearly "gentler" for everyone